begun for a prospective coronavirus vaccine, but its Quebec-based manufacturer is already downplaying its potential impact.Dr.
Bruce Clark, president and CEO of the biopharmaceutical company Medicago, cautioned observers against holding unrealistic expectations that his product — or any of the numerous vaccines in development globally — will bring the pandemic to a screeching halt.“Whatever vaccine we get in this first round — unless it’s a miracle — it’s not going to be perfect,” said Clark, whose company began trials for its proposed vaccine Monday in Quebec City.“It’s going to have to undergo development.
It’s going to take probably years to come up with an understanding of the right vaccine, the right approach. It’s not the panacea.“To.